Table 1.
Characteristic | control group (n = 45) | Lidocaine group(n = 36) | study group (n = 50) | F value or χ2 value | P Value |
---|---|---|---|---|---|
Weight, kg | 57.2 ± 5.1 | 56.3 ± 5.3 | 55.8 ± 4.7 | 1.01 | 0.36 |
Body mass index | 23.2 ± 3.8 | 22.4 ± 2.6 | 22.8 ± 2.9 | 0.66 | 0.52 |
Mean age (y) | 45.4 ± 3.2 | 44.2 ± 3.6 | 46.7 ± 4.8 | 1.87 | 0.16 |
Mean uterine size (mL) | |||||
Median | 268.3 | 562.5 | 293.9 | 0.03 | 0.99 |
Range (25%–75%) | 201.0–1095.6 | 258.3–953.1 | 195.5–1145.3 | ||
Mean largest tumor size (mL) | |||||
Median | 67.3 | 163.8 | 99.8 | 0.49 | 0.78 |
Range (25%–75%) | 51.6–258.6 | 103.3–331.5 | 56.8–503.4 | ||
Primary symptom | |||||
Menorrhagia (n) | 36 | 31 | 41 | 0.53a | 0.77 |
Dysmenorrhea (n) | 20 | 23 | 26 | 3.05a | 0.22 |
Pelvic pressure (n) | 24 | 20 | 25 | 0.38a | 0.83 |
Bloating (n) | 39 | 35 | 43 | 3.27a | 0.20 |
Constant urination (n) | 31 | 30 | 38 | 2.27a | 0.32 |
Note: n: numbers.